These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7378122)

  • 1. The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects.
    Catapano AL
    Atherosclerosis; 1980 Apr; 35(4):419-24. PubMed ID: 7378122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid assessment of the distribution of apolipoproteins C-II and C-III subspecies in triglyceride-rich lipoproteins by isoelectric focusing.
    Bugugnani MJ; Koffigan M; Kora I; Ouvry D; Clavey V; Fruchart JC
    Clin Chem; 1984 Mar; 30(3):349-51. PubMed ID: 6697477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
    Huff MW; Breckenridge WC; Strong WL; Wolfe BM
    Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject.
    Huff MW; Evans AJ; Wolfe BM; Connelly PW; Maguire GF; Strong WL
    J Lipid Res; 1990 Mar; 31(3):385-96. PubMed ID: 2341805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography.
    Bukberg PR; Le NA; Ginsberg HN; Gibson JC; Goldman LC; Brown WV
    J Lipid Res; 1983 Sep; 24(9):1251-60. PubMed ID: 6631249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and isolation of human apolipoproteins C-II, C-III0, C-III1, and C-III2 by chromatofocusing on the Fast Protein Liquid Chromatography system.
    Huff MW; Strong WL
    J Lipid Res; 1987 Sep; 28(9):1118-23. PubMed ID: 3655564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
    Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
    J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of severe caloric restriction on the degree of sialylation of apoprotein C-III in obese women.
    Bosello O; Cominacini L; Zocca I; Garbin U; Ferrari F; Davoli A
    Ann Nutr Metab; 1985; 29(1):33-9. PubMed ID: 3977292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia.
    Cohn JS; Tremblay M; Batal R; Jacques H; Rodriguez C; Steiner G; Mamer O; Davignon J
    Atherosclerosis; 2004 Nov; 177(1):137-45. PubMed ID: 15488876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
    Cohn JS; Patterson BW; Uffelman KD; Davignon J; Steiner G
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel type hypertriglyceridemia observed in FLS mice.
    Takahashi M; Saibara T; Nemoto Y; Ono M; Akisawa N; Iwasaki S; Toda K; Ogawa Y; Wakatsuki A; Inagaki S; Onishi S
    Lipids; 2003 Jul; 38(7):687-92. PubMed ID: 14506831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
    Wang CS; McConathy WJ; Kloer HU; Alaupovic P
    J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of short-term and prolonged fructose intake on VLDL-TG and relative properties on apo CIII1 and apo CII in the VLDL fraction in type IV hyperlipoproteinaemia.
    Cybulska B; Naruszewicz M
    Nahrung; 1982; 26(3):253-61. PubMed ID: 7110307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing.
    Catapano AL; Jackson RL; Gilliam EB; Gotto AM; Smith LC
    J Lipid Res; 1978 Nov; 19(8):1047-52. PubMed ID: 32216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.